MO

Altria Group Inc. (MO)

Stock · NYSE · Health Care

$68.65as of 8/28/2026

AI Market Commentary

AI-generated

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

August 29, 2026

Altria and Philip Morris Sign Manufacturing Pact. Altria and Philip Morris have signed a manufacturing agreement, a development that brings the two tobacco companies back into a closer operational relationship. Several recent articles highlight Altria as a high-yielding dividend name, with a yield above 9% and a spot among dividend-focused portfolios. The stock is trading in the middle of its 52-week range, with an RSI near 50, suggesting neither strong momentum nor weakness ahead of the news. The new pact is the main catalyst to watch, while the dividend profile remains a recurring theme across recent coverage.

Active signals

Support level
$64.71
Industry
Medicinal Chemicals and Botanical Products

About MO

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. It offers cigarettes primarily under the Marlboro brand; large cigars and pipe tobacco under the Black & Mild brand; moist smokeless tobacco and oral tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands; oral nicotine pouches under the on! brand; and e-vapor products under…

Sector
Health Care
Industry
Medicinal Chemicals and Botanical Products
Employees
5,900

Fundamentals

1-day range
$67.7$68.75
Market cap
$113.98B
P/E (trailing)
13.75
P/E (forward)
11.71
EPS (trailing)
$4.76
Dividend yield
9.45%
Beta
0.47
Avg. volume
8.67M
Ex-dividend date
June 15, 2026
Dividend pay date
July 10, 2026
52-week range
$54.7$77.06
Next earnings: October 29, 2026 · EPS estimate $1.51Before Openconfirmed

How Altria Group Inc. Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$23.28BNet Income$6.95B (30%)Other$8.29B (36%)Cost of Revenue$5.60B (24%)Tax$2.44B (10%)MO

Source: 10-K filed Feb 25, 2026 · via SEC EDGAR / Finnhub

Forecasts

11 analyst ratings

Buy 50%
Hold 38%
Sell 13%
1-year price forecast
High
$82
+19.4%
Median
$71
+3.4%
Low
$58
-15.5%

Altria Group Inc. Competitors

Chosen by industry and closest market cap.

  • MO
    Altria Group Inc.
    $68.67
    ▲ 1.47%
    Market cap $113.98BP/E 13.75
    $54.7$77.06
  • BTI
    British American Tobacco Industries p.l.c. Common Stock ADR
    $56.12
    ▼ 0.28%
    Market cap $129.12BP/E 13.89
    $3,677$5,004
  • DFTX
    Definium Therapeutics Inc. Common Shares
    $41
    ▼ 6.44%
    Market cap $4.56BP/E
    $8.7$49.7
  • RLX
    RLX Technology Inc. American Depositary Shares each representing the right to receive one (1) Class A ordinary share
    $1.83
    ▲ 1.67%
    Market cap $3.08BP/E 16.68
    $1.76$2.84
  • RGC
    Regencell Bioscience Holdings Limited Ordinary Shares
    $5.52
    ▼ 0.09%
    Market cap $3.03BP/E
    $4.51$69
  • TRLV
    Trulieve Cannabis Corp. Subordinate Voting Shares
    $11.82
    ▲ 7.16%
    Market cap $1.65BP/E
    $7.82$12.3
  • GLAS
    Glass House Brands Inc. Subordinate Voting Shares
    $9.92
    ▲ 1.43%
    Market cap $790.50MP/E
    $5.03$14

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions
Acquired
65.9K
Disposed
35.7K

Institutional Ownership

March 31, 2026

Total shares held
986.99M
Total value held
$63.39B
Institutional holders
2441
Top holders this quarter
  • Unknown124.75M
  • Unknown108.84M
  • Unknown71.79M
  • Unknown54.28M
  • Unknown47.02M
  • Unknown25.68M
  • Unknown24.46M
  • Unknown23.84M
  • Unknown21.50M
  • Unknown18.42M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.